Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Chlorhexidine (Irrisept) versus normal saline rinse for flap closure in pilonidal disease

Official title: Effect of Antiseptic Irrigations With 0.05% Chlorhexidine Gluconate (Irrisept) Versus Normal Saline on Fasciocutaneous Flap-Based Closure of Pilonidal Disease With Myriad Extracellular Matrix Implantation

Run by Nasseri,Yosef MD · NCT07321704 · Data updated 2026-11-12

This will see if rinsing the surgical wound with Irrisept (0.05% chlorhexidine) instead of normal saline reduces infections and other wound problems in adults having fasciocutaneous flap surgery for pilonidal disease.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment60 (estimated)
SponsorNasseri,Yosef MD
Academic / other
Locations1 site (Los Angeles, California)
StatusRecruiting
StartedFebruary 17, 2026
Main results expectedJune 1, 2027
Study endsDecember 1, 2027
Registry record updatedMarch 27, 2026
Trial IDNCT07321704 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 18 and older who are scheduled for bilateral gluteal fasciocutaneous flap closure with extracellular matrix implantation for pilonidal disease and who can give informed consent are ideal candidates.

Probably not a fit

Patients with a known allergy to chlorhexidine, uncontrolled wound infection, full-thickness burns, pregnant or lactating women, or those otherwise judged unsuitable by the investigator are unlikely to benefit from this intervention.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Adults undergoing bilateral gluteal fasciocutaneous flap closure with implantation of an extracellular matrix for pilonidal disease will receive wound irrigation with either Irrisept (0.05% chlorhexidine gluconate) or standard normal saline prior to surgical closure. The study prospectively compares post-operative outcomes including infection, seroma, hematoma, wound dehiscence, and time to complete wound healing between the two irrigation groups. Participants will be treated at a single clinical site and followed after surgery for healing progress and any adverse events. Standard perioperative care aside from the assigned irrigation solution will be followed.

Why it matters

Potential benefit: If successful, using Irrisept could reduce post-operative infections and wound complications and speed healing after flap closure for pilonidal disease.

How similar studies have gone: Antiseptic irrigation with chlorhexidine has reduced surgical site infections in some other surgical settings, but its specific benefit for pilonidal flap closure is not well established.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Willing and able to provide written informed consent and to comply with the requirements of the Clinical Investigational Plan
2. Male or female patients aged 18 years or above
3. Patients scheduled for flap-based procedure for pilonidal disease with planned use of Irrisept or normal saline irrigation
4. Subjects who are willing and able to comply with all aspects of the treatment and evaluation schedule

Exclusion Criteria:

1. Known allergy to contents of Irrisept (chlorhexidine gluconate)
2. Full-thickness ('third degree') burns
3. Wounds with uncontrolled clinical infection (CDC Contamination Grade 4)
4. Any medical condition or serious intercurrent illness that, in the opinion of the investigator, may make it undesirable for the patient to participate in the study
5. Currently participating or has participated in another clinical study within 30 days prior to enrollment
6. Pregnant or lactating women
7. Any subject who, at the discretion of the Investigator, is not suitable for inclusion in the study

Where it's running

  • Surgery Group LA
    Los Angeles, California, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Browse more
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.